| pubmed-article:11445001 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0439830 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0041618 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C1719039 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:11445001 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:11445001 | pubmed:dateCreated | 2003-10-29 | lld:pubmed |
| pubmed-article:11445001 | pubmed:abstractText | Ultrasonography with 20 MHz frequency can be used to estimate tumour thickness preoperatively in malignant melanoma (MM) of the skin. The vertical invasion depth is the single most important prognostic factor for localised MM, and its preoperative knowledge would be very useful for the planning of surgical procedures. Since ultrasonographic distance measurements directly depend upon the tissue specific ultrasound velocity, we determined the ultrasound velocity in primary melanoma. | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11445001 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11445001 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11445001 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11445001 | pubmed:author | pubmed-author:MohrPP | lld:pubmed |
| pubmed-article:11445001 | pubmed:author | pubmed-author:BreitbartE... | lld:pubmed |
| pubmed-article:11445001 | pubmed:author | pubmed-author:WeichenthalMM | lld:pubmed |
| pubmed-article:11445001 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11445001 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11445001 | pubmed:pagination | 1 | lld:pubmed |
| pubmed-article:11445001 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:meshHeading | pubmed-meshheading:11445001... | lld:pubmed |
| pubmed-article:11445001 | pubmed:articleTitle | The velocity of ultrasound in human primary melanoma tissue - implications for the clinical use of high resolution sonography. | lld:pubmed |
| pubmed-article:11445001 | pubmed:affiliation | Department of Dermatology, St. Georg Hospital, Hamburg, Germany. weichenthal@uke.uni-hamburg.de | lld:pubmed |
| pubmed-article:11445001 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11445001 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:11445001 | pubmed:publicationType | Validation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11445001 | lld:pubmed |
